Home / Rivastigmine / Austria
AT ATC N06DA03 · updated 2 Nov 2026
Rivastigmine shortage in Austria
Is there a Rivastigmine shortage in Austria?
Yes. As of 2 Nov 2026, 4 Rivastigmine products are reported short in Austria, the first since 8 Sep 2026. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in United States, Italy, Spain, Belgium, Sweden. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Nimvastid 1,5 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 8 Sep 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Nimvastid 6 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 8 Sep 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Rivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster, 30 Stück | Sandoz GmbH | 14 Sep 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Nimvastid 3 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 22 Oct 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).